Your browser doesn't support javascript.
loading
Efficacy of omalizumab for extracutaneous symptoms of chronic spontaneous urticaria.
Belbezier, Aude; Boccon-Gibod, Isabelle; Bouillet, Laurence.
Affiliation
  • Belbezier A; Department of Internal medicine and Clinical Immunology, CREAK, Grenoble Alpes University Hospital, Grenoble, France.
  • Boccon-Gibod I; Department of Internal medicine and Clinical Immunology, CREAK, Grenoble Alpes University Hospital, Grenoble, France.
  • Bouillet L; Department of Internal medicine and Clinical Immunology, CREAK, Grenoble Alpes University Hospital, Grenoble, France.
Eur J Dermatol ; 31(1): 86-87, 2021 Feb 01.
Article in En | MEDLINE | ID: mdl-33772528
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anti-Allergic Agents / Omalizumab / Chronic Urticaria Type of study: Diagnostic_studies / Observational_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Eur J Dermatol Journal subject: DERMATOLOGIA Year: 2021 Document type: Article Affiliation country: France Country of publication: France
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anti-Allergic Agents / Omalizumab / Chronic Urticaria Type of study: Diagnostic_studies / Observational_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Eur J Dermatol Journal subject: DERMATOLOGIA Year: 2021 Document type: Article Affiliation country: France Country of publication: France